Halometasone
From Wikipedia, the free encyclopedia
|
Halometasone
|
|
| Systematic (IUPAC) name | |
| (6S,8S,9R,10S,11S,13S,16R,17R)-2-chloro- 6,9-difluoro-11,17-dihydroxy-17-(2-hydroxy acetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15, 16-octahydrocyclopenta[a]phenanthren-3-one |
|
| Identifiers | |
| CAS number | |
| ATC code | D07 |
| PubChem | |
| Chemical data | |
| Formula | C22H27ClF2O5 |
| Mol. mass | 444.896 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Halometasone is a corticosteroid.

